Date Filed | Type | Description |
08/25/2023 |
4
| Farfel Gail M (CEO) has filed a Form 4 on ProMIS Neurosciences Inc.
Txns:
| Granted 53,192 shares
@ $0 Granted 53,192 options to buy
@ $1.75, valued at
$93.1k
|
|
06/08/2023 |
4
| Farfel Gail M (Director) has filed a Form 4 on AVROBIO, Inc.
Txns:
| Granted 17,643 options to buy
@ $1.09, valued at
$19.2k
|
|
12/16/2022 |
4
| Farfel Gail M (CEO) has filed a Form 4 on ProMIS Neurosciences Inc.
Txns:
| Bought 1,000 shares
@ $4.94, valued at
$4.9k
|
|
12/08/2022 |
4
| Farfel Gail M (CEO) has filed a Form 4 on ProMIS Neurosciences Inc.
Txns:
| Bought 1,000 shares
@ $5.7, valued at
$5.7k
|
|
09/20/2022 |
4
| Farfel Gail M (CEO) has filed a Form 4 on ProMIS Neurosciences Inc.
Txns:
| Granted 208,334 options to buy
@ $0 |
|
09/20/2022 |
3
| Farfel Gail M (CEO) has filed a Form 3 on ProMIS Neurosciences Inc. |
06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2022 |
4
| Farfel Gail M (Director) has filed a Form 4 on AVROBIO, Inc.
Txns:
| Granted 17,478 options to buy
@ $1.06, valued at
$18.5k
|
|
05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/21/2020 |
4
| Farfel Gail M (Director) has filed a Form 4 on AVROBIO, Inc.
Txns:
| Granted 28,000 options to buy
@ $16.14, valued at
$451.9k
|
|
10/21/2020 |
3
| Farfel Gail M (Director) has filed a Form 3 on AVROBIO, Inc. |
06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/18/2020 |
4
| Farfel Gail M (Director) has filed a Form 4 on DURECT CORP
Txns:
| Granted 55,000 options to buy
@ $2.33, valued at
$128.2k
|
|
05/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/23/2019 |
4
| Farfel Gail M (EVP/Chief Development Officer) has filed a Form 4 on ZOGENIX, INC.
Txns:
| Sold 3,446 shares
@ $52, valued at
$179.2k
|
|
04/25/2019 |
4
| Farfel Gail M (Director) has filed a Form 4 on DURECT CORP
Txns:
| Granted 70,000 options to buy
@ $0.5684, valued at
$39.8k
|
|
04/25/2019 |
3
| Farfel Gail M (Director) has filed a Form 3 on DURECT CORP |
03/26/2019 |
4
| Farfel Gail M (EVP/Chief Development Officer) has filed a Form 4 on ZOGENIX, INC.
Txns:
| Granted 63,750 options to buy
@ $52.66, valued at
$3.4M
Granted 8,125 restricted stock units
@ $0 |
|
03/19/2019 |
4
| Farfel Gail M (EVP/Chief Development Officer) has filed a Form 4 on ZOGENIX, INC.
Txns:
| Paid exercise price by delivering 488 shares
@ $51.88, valued at
$25.3k
Exercised 1,625 restricted stock units
@ $0 |
|
10/09/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/05/2018 |
4
| Farfel Gail M (EVP/Chief Development Officer) has filed a Form 4 on ZOGENIX, INC.
Txns:
| Sold 4,700 shares
@ $47.2702, valued at
$222.2k
Sold 2,300 shares
@ $48.2054, valued at
$110.9k
Exercised 7,000 options to buy
@ $13.96, valued at
$97.7k
|
|
08/10/2018 |
4
| Farfel Gail M (EVP/Chief Development Officer) has filed a Form 4 on ZOGENIX, INC.
Txns:
| Sold 5,100 shares
@ $52.4152, valued at
$267.3k
Sold 1,900 shares
@ $53.1553, valued at
$101k
Exercised 7,000 options to buy
@ $13.96, valued at
$97.7k
|
|
06/13/2018 |
4
| Farfel Gail M (EVP/Chief Development Officer) has filed a Form 4 on ZOGENIX, INC.
Txns:
| Sold 5,118 shares
@ $45, valued at
$230.3k
Exercised 5,000 options to buy
@ $13.96, valued at
$69.8k
|
|
03/16/2018 |
4
| Farfel Gail M (EVP/Chief Development Officer) has filed a Form 4 on ZOGENIX, INC.
Txns:
| Granted 40,000 options to buy
@ $42.65, valued at
$1.7M
Granted 6,500 restricted stock units
@ $0 |
|
|